A Whole New Market Is Giving This Cancer-Testing Stock A Boost
Shares of Exact Sciences – the company behind the at-home colon-cancer test Cologuard – got a boost recently when the FDA approved (earlier than expected)…
Cancer Research
These 3 Biotech Stocks May Be The Best Pure Plays On Two Remarkable Advances In Cancer Treatment
A number of conferences have recently taken place where cancer researchers have revealed the latest and most promising developments in the fight against this disease.…